UFP Technologies, Inc. (UFPT)
| Market Cap | 1.77B +5.0% |
| Revenue (ttm) | 608.85M +11.2% |
| Net Income | 68.62M +8.1% |
| EPS | 8.78 +7.8% |
| Shares Out | 7.74M |
| PE Ratio | 26.08 |
| Forward PE | 23.91 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 161,438 |
| Open | 226.00 |
| Previous Close | 226.10 |
| Day's Range | 221.58 - 230.65 |
| 52-Week Range | 173.86 - 274.93 |
| Beta | 1.08 |
| Analysts | Strong Buy |
| Price Target | 289.00 (+26.22%) |
| Earnings Date | May 4, 2026 |
About UFPT
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment ... [Read more]
Financial Performance
In 2025, UFP Technologies's revenue was $602.80 million, an increase of 19.50% compared to the previous year's $504.42 million. Earnings were $68.31 million, an increase of 15.82%.
Financial StatementsAnalyst Summary
According to one analyst, the rating for UFPT stock is "Strong Buy" and the 12-month stock price target is $289.0.
News
UFP Technologies Earnings Call Transcript: Q1 2026
Revenue grew 4.1% year-over-year, led by strong medical segment growth and new program launches, while non-medical sales declined as automotive is phased out. Margin improvement is expected in the second half as new programs ramp and cost headwinds subside.
UFP Technologies Earnings release: Q1 2026
UFP Technologies released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
UFP Technologies Quarterly report: Q1 2026
UFP Technologies has published its Q1 2026 quarterly earnings report on May 5, 2026.
UFP Technologies reports Q1 adjusted EPS $2.48, consensus $2.31
Reports Q1 revenue $154.2M, consensus $154.78M. “I am pleased with our first quarter results and continued progress with our strategic initiatives,” said Jeffrey Bailly, Chairman and CEO. “Revenue gre...
UFP Technologies Announces Strong Q1 Results
NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, tod...
UFP Technologies to Report First Quarter 2026 Financial Results on May 4, 2026
NEWBURYPORT, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient me...
UFP Technologies Proxy statement: Proxy filing
UFP Technologies filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
UFP Technologies Transcript: 47th Annual Raymond James Institutional Investor Conference
A leading CDMO in medical devices leverages exclusive material access, strategic acquisitions, and deep customer partnerships to drive high-margin growth. Recent contract extensions, robust financial performance, and expansion into new geographies position the company for continued outperformance.
UFP Technologies Slides: Investor presentation
UFP Technologies has posted slides in relation to its latest quarterly earnings report, which was published on March 2, 2026.
UFP Technologies targeting 12%-18% revenue growth in 3-5 years
Other 3-5 year financial targets include 28%-31% gross margin and 17%-20% operating margin. Comments taken from investor presentation slides.
UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
NEWBURYPORT, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies Earnings Call Transcript: Q4 2025
Revenue grew 19.5% to $602.8M, with strong gains in operating income and EPS. Labor inefficiencies and a cybersecurity breach were managed effectively, and robust growth is expected in patient services and medical submarkets, supported by contract extensions and facility expansions.
UFP Technologies Annual report: Q4 2025
UFP Technologies has published its Q4 2025 annual report on February 25, 2026.
UFP Technologies Earnings release: Q4 2025
UFP Technologies released its Q4 2025 earnings on February 25, 2026, summarizing the period's financial results.
UFP Technologies Annual report: Q4 2025
UFP Technologies has published its Q4 2025 annual report on February 25, 2026.
UFP Technologies reports Q4 adjusted EPS $2.44, consensus $2.23
Reports Q4 revenue $148.915M, consensus $149.07M. “I am pleased with our 2025 results and our progress on a number of key strategic initiatives,” said R. Jeffrey Bailly, CEO. “Sales for…
UFP Technologies Announces Record 2025 Results
NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
These 3 Small-Cap Stocks Are Built to Weather a Slowdown
The Russell 2000 index, commonly referred to as the “small-cap index,” has increased by approximately 6% over the past three months. This rise is mainly driven by changes in interest rates, as the Fed...
UFP Technologies Transcript: Piper Sandler 37th Annual Healthcare Conference
A Medtech-focused CDMO with $600M revenue leverages exclusive material access, custom engineering, and strategic acquisitions to drive double-digit growth in high-value markets. Long-term contracts, strong customer relationships, and a proven management team underpin robust financial targets and sustained outperformance.
UFP Technologies announces CEO Bailly to retire, Rock to assume position
UFP Technologies (UFPT) announced that R. Jeffrey Bailly will retire as CEO at the Company’s next annual meeting on June 4, 2026. At that time, Mitchell Rock, President of the…
UFP Technologies Announces CEO Succession Plan
NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference
NEWBURYPORT, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) a contract development and manufacturing organization that specializes in single-use and single-patient medi...
UFP Technologies Earnings Call Transcript: Q3 2025
Q3 sales grew 6.5% to $154.6M, led by MedTech and strong segment growth, despite a $3M labor inefficiency at AJR that reduced margins and EPS. Backlog remains high, with new programs and contract expansions expected to drive future growth.
UFP Technologies Quarterly report: Q3 2025
UFP Technologies has published its Q3 2025 quarterly earnings report on November 4, 2025.